A critical advance in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in various kinds of cancer, leading uncontrolled https://socialistener.com/story7409675/nanobodies-revive-p53-new-promising-approach-for-malignant-therapy